Overview and Definition

Categorized as generalized nonmotor onset seizures.
Characterized by sudden, brief lapses of consciousness.
Originate within and rapidly engage neuronal networks distributed across both cerebral hemispheres.
Manifest clinically as behavioral arrest or staring spells.
Lack associated loss of postural tone (patient does not fall).
Display no postictal confusion or postictal state.
Immediate resumption of pre-seizure activity occurs upon cessation.
Represent predominant seizure type in 15–20% of childhood epilepsies.

Pathophysiology

Emanate from abnormal oscillatory rhythms normally generated during sleep.
Utilize neural circuits connecting thalamus and cerebral cortex.
Mechanism involves aberrant interaction between three specific components within the thalamus:
- GABA-B receptors.
- T-type Calcium (Ca2+) channels.
- Potassium (K+) channels.

Onset: Typically 4–10 years (peak 5–8 years).
Frequency: Can occur hundreds of times daily.
Clinical Features:
- Sudden onset and cessation.
- Duration usually 10–15 seconds.
- Motionless blank stare.
- Accompanied by subtle, bilateral motor signs (rapid eyelid blinking, chewing movements, small-amplitude clonic hand movements).
- Simple automatisms present (lip smacking, picking at clothing).
- Slight forward head drop occasionally noted.
Precipitants: Provoked reliably by 3–5 minutes of hyperventilation.
Prognosis: Good; remission typically achieved by 10–12 years of age. Approximately 25% eventually develop generalized tonic-clonic seizures.

Clinical Features:
- Lapses of consciousness possess longer duration.
- Less abrupt clinical onset and cessation.
- Pronounced motor signs (head atonia, severe myoclonus).
- Precipitation by drowsiness.
Associations:
- Diffuse or multifocal structural brain abnormalities.
- Significant neurologic dysfunction (e.g., mental retardation).
- Core component of Lennox-Gastaut Syndrome.
Prognosis: Poor; highly resistant to standard anticonvulsant therapy.

Onset: 1–12 years.
Clinical Features: Accompanied by periorbital, perioral, or limb myoclonic jerks.
Prognosis: Guarded; notoriously difficult to control with medications.

Hyperventilation testing in clinical setting (3-5 minutes) highly effective for precipitating typical absence seizures and concurrent EEG discharges.

Seizure Subtype	Hallmark EEG Findings
Typical Absence	- Generalized, symmetric 3-Hz spike-and-slow-wave discharges. - Superimposed on normal EEG background. - Sudden onset and termination.
Atypical Absence	- Generalized, slow spike-and-slow-wave pattern (≤2.5 Hz). - Abnormal interictal background activity.
Juvenile Absence	- 4–6 Hz spike-and-slow-wave discharges. - Polyspike-and-slow-wave discharges.

Glucose Transporter Defect (SLC2A1):
- Indicated if absence seizures present before 4 years of age.
- Indicated in drug-resistant typical absence seizures.
- Characterized by low Cerebrospinal Fluid (CSF) glucose levels.
- Requires SLC2A1 transporter gene sequencing.
- Therapeutic intervention: Ketogenic diet.

Proper classification prevents catastrophic misdiagnosis and erroneous prescribing.

Feature	Typical Absence Seizure	Focal Seizure with Impaired Awareness (Complex Partial)	Behavioral Staring / Daydreaming
Aura	Absent.	Frequently present (e.g., epigastric rising, fear, olfactory).	Absent.
Duration	Brief (seconds; 10-15s).	Longer (1-2 minutes).	Variable; ends upon distraction.
Motor Signs	Subtle blinking, minor automatisms.	Florid, complex automatisms (walking, shuffling, repetitive manual tasks).	None.
Postictal State	Absent. Immediate return to baseline.	Present. Confusion, lethargy, or aphasia lasting minutes to hours.	Absent.
Precipitants	Hyperventilation.	Sleep deprivation, stress.	Inattention, fatigue, boredom.
Responsiveness	Unresponsive to tactile/verbal stimuli.	Unresponsive during ictal phase.	Responds to touch or loud stimulus.
Misdiagnosis Risk	Attention-Deficit Disorder (ADHD).	Psychiatric/Behavioral disorders.	Absence Epilepsy.

Therapy targets specific thalamic T-type calcium channels or provides broad-spectrum generalized seizure coverage.

Medication	Mechanism of Action	Efficacy / Indications	Side Effects & Nuances
Ethosuximide	Inhibits T-type Ca2+ channels in thalamic neurons.	Highly effective for uncomplicated typical absence seizures. Ineffective against focal or generalized tonic-clonic seizures.	Lethargy, ataxia, GI irritation, headache. Requires periodic blood counts (rare bone marrow suppression).
Valproic Acid	Inhibits T-type Ca2+ channels, inhibits GABA transaminase, acts on GABAB receptors.	Highly effective. Preferred if concurrent generalized tonic-clonic or myoclonic seizures exist.	Hepatotoxicity, thrombocytopenia, weight gain, alopecia. Contraindicated in suspected POLG mitochondrial disease. Teratogenic in women of childbearing age.
Lamotrigine	Inhibits voltage-gated Na+ channels, voltage-gated Ca2+ channels, attenuates glutamate.	Effective first-line alternative, especially for mixed seizure types. Less toxic than Valproate.	Sedation, ataxia. Black box warning: Stevens-Johnson syndrome. Must initiate slowly.

Acetazolamide: Utilized as alternative or add-on.
Zonisamide: Blocks T-type calcium channels. Alternative for refractory cases.
Clonazepam: Effective alternative but limited by significant sedation, drooling, hyperactivity, and rapid development of tolerance.
Topiramate: Considered alternative therapy; blocks AMPA/kainate receptors.
Ketogenic Diet: Highly effective adjunctive therapy, especially in medically refractory cases or SLC2A1 mutations.

Specific antiepileptic drugs strictly contraindicated as they paradoxically exacerbate absence seizures: